中文名称: FW1256
英文名称: FW1256
CAS No: 117089-08-4
分子式: C12H10NOPS
分子量: 247.25
F10287 FW1256 ≥98% (psaitong)
包装规格:
5mg in glass bottle
溶解性:
溶于DMSO(≥ 250 mg/mL)
产品描述:

基本信息

产品编号:

F10287

产品名称:

FW1256

CAS:

117089-08-4

 

储存条件

粉末

-20℃

四年

 

 

分子式:

C12H10NOPS

溶于液体

-80℃

6个月

分子量:

247.25

-20℃

1个月

化学名: 

1,3,2-Benzoxazaphosphole,2,3-dihydro-2-phenyl-,2-sulfide

Solubility (25°C):

 

体外:

 

DMSO

 

Ethanol

 

Water

 

体内(现配现用):

 

1mg/ml表示微溶或不溶。

普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。

 

制备储备液

 

浓度

 

溶液体积

质量

 

1mg

 

5mg

 

10mg

1mM

4.0445mL

20.2224mL

40.4449mL

5mM

0.8089mL

4.0445mL

8.0890mL

10mM

0.4044mL

2.0222mL

4.0445mL

 

生物活性

产品描述

一种苯基类似物,也是一种缓释硫化氢(H2S)供体。

靶点

NF-κB;Apoptosis

 

体外研究

FW1256 (200µM;24.5 hours;AW264.7 cells) treatment significantly reduces IL-1β,COX-2 and iNOS mRNA and protein in LPSstimulated RAW264.7 macrophages.FW1256 (200µM;24.5 hours;AW264.7 cells) treatment significantly reduces IL-1β,COX-2 and iNOS PROTE and protein in LPSstimulated RAW264.7 macrophages.FW1256 concentration dependently decreases TNF-α(IC50 of 61.2µM),IL-6 (IC50 of 11.7µM),PGE2 (IC50 of 25.5µM) and NO (IC50 of 34.6µM) generation in LPS-stimulated RAW264.7 macrophages and bone marrow-derived macrophages (BMDMs) (IC50s of 414.9µM,300.2µM,4µM and 9.5µM for TNF-α,IL-6,PGE2 and NO,respectively).FW1256 decreases NF-κB activation as evidenced by reduced cytosolic phospho-IκBα levels and reduces nuclear p65 levels in LPS-stimulated RAW264.7 macrophages treated with FW1256.

RT-PCR

Cell Line:

RAW264.7 cells

Concentration:

200µM

Incubation Time:

24.5 hours

Result:

Significantly reduced IL-1β,COX-2 and iNOS mRNA in LPS-stimulated RAW264.7 macrophages..

Western Blot Analysis

Cell Line:

RAW264.7 cells

Concentration:

200µM

Incubation Time:

24.5 hours

Result:

Significantly reduced IL-1β,COX-2 and iNOS proteinin LPS-stimulated RAW264.7 macrophages..

体内研究

FW1256 (100mg/kg;intraperitoneal injection;male C57BL/6 mice) treatment reduces IL-1β,TNFα,nitrate/nitrite and PGE2 levels in LPS-treated mice.

Animal Model:

Male C57BL/6 mice (20-25g,6-10 weeks) injected with E.coli lipopolysaccharide (LPS)

Dosage:

100mg/kg

Administration:

Intraperitoneal injection

Result:

Reduced IL-1β,TNFα,nitrate/nitrite and PGE2 levels in LPS-treated mice.

保存条件:
-20℃
UN码:
HazardClass:
危害声明:
安全说明:
搜索质检报告(COA)
参考文献 & 客户发表文献

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • =
    *
    *
    *选择对应的单位 *空出希望得到的变量,填写另外两个变量

用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )

  • * = *

连续稀释计算器方程

  • 连续稀释

  • 初始浓度:
  • 稀释倍数:
  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):